2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide

C52H83N11O22 — CID 71460075

IUPAC2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide
SMILESCCCCCCCCCCC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)C[C@@H]1CC(=O)N[C@H](CO)C(=O)N[C@H]([C@H](O)c2ccc(O)cc2)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1
InChIInChI=1S/C52H83N11O22/c1-2-3-4-5-6-7-8-9-10-11-35(85-52-45(77)44(76)34(68)24-84-52)43(75)33(67)16-26-17-39(72)59-31(22-64)50(82)63-41(42(74)25-12-14-27(66)15-13-25)51(83)61-28(18-36(53)69)46(78)56-21-40(73)58-29(19-37(54)70)48(80)62-32(23-65)49(81)60-30(20-38(55)71)47(79)57-26/h12-15,26,28-35,41-45,52,64-68,74-77H,2-11,16-24H2,1H3,(H2,53,69)(H2,54,70)(H2,55,71)(H,56,78)(H,57,79)(H,58,73)(H,59,72)(H,60,81)(H,61,83)(H,62,80)(H,63,82)/t26-,28-,29+,30+,31-,32+,33-,34-,35+,41-,42-,43-,44+,45-,52+/m1/s1
InChIKeyIRPZALKPQWMSQP-DDAPKMJSSA-N
MW1214.29 g/mol
LogP-8.19
Rot. Bonds26

About 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide

2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide (PubChem CID 71460075) has the molecular formula C52H83N11O22 and a molecular weight of 1214.29 g/mol. Its IUPAC name is 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide.

Molecular Properties

Compound Name2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide
PubChem CID71460075
Molecular FormulaC52H83N11O22
Molecular Weight1214.29 g/mol
Exact Mass1213.57
IUPAC Name2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide
SMILESCCCCCCCCCCC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)C[C@@H]1CC(=O)N[C@H](CO)C(=O)N[C@H]([C@H](O)c2ccc(O)cc2)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1
InChIInChI=1S/C52H83N11O22/c1-2-3-4-5-6-7-8-9-10-11-35(85-52-45(77)44(76)34(68)24-84-52)43(75)33(67)16-26-17-39(72)59-31(22-64)50(82)63-41(42(74)25-12-14-27(66)15-13-25)51(83)61-28(18-36(53)69)46(78)56-21-40(73)58-29(19-37(54)70)48(80)62-32(23-65)49(81)60-30(20-38(55)71)47(79)57-26/h12-15,26,28-35,41-45,52,64-68,74-77H,2-11,16-24H2,1H3,(H2,53,69)(H2,54,70)(H2,55,71)(H,56,78)(H,57,79)(H,58,73)(H,59,72)(H,60,81)(H,61,83)(H,62,80)(H,63,82)/t26-,28-,29+,30+,31-,32+,33-,34-,35+,41-,42-,43-,44+,45-,52+/m1/s1
InChIKeyIRPZALKPQWMSQP-DDAPKMJSSA-N
XLogP-8.19
TPSA562.60 Ų
H-Bond Donors20
H-Bond Acceptors22
Rotatable Bonds26
Heavy Atoms85
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001214.29
LogP ≤ 5-8.19
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide?
The IUPAC name of 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide (CID 71460075) is 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide.
What is the SMILES notation for 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide?
The canonical SMILES for 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide is CCCCCCCCCCC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)C[C@@H]1CC(=O)N[C@H](CO)C(=O)N[C@H]([C@H](O)c2ccc(O)cc2)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1.
What is the InChIKey of 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide?
The InChIKey is IRPZALKPQWMSQP-DDAPKMJSSA-N. The full InChI is InChI=1S/C52H83N11O22/c1-2-3-4-5-6-7-8-9-10-11-35(85-52-45(77)44(76)34(68)24-84-52)43(75)33(67)16-26-17-39(72)59-31(22-64)50(82)63-41(42(74)25-12-14-27(66)15-13-25)51(83)61-28(18-36(53)69)46(78)56-21-40(73)58-29(19-37(54)70)48(80)62-32(23-65)49(81)60-30(20-38(55)71)47(79)57-26/h12-15,26,28-35,41-45,52,64-68,74-77H,2-11,16-24H2,1H3,(H2,53,69)(H2,54,70)(H2,55,71)(H,56,78)(H,57,79)(H,58,73)(H,59,72)(H,60,81)(H,61,83)(H,62,80)(H,63,82)/t26-,28-,29+,30+,31-,32+,33-,34-,35+,41-,42-,43-,44+,45-,52+/m1/s1.
What are the key properties of 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide?
2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide has a molecular weight of 1214.29 g/mol, XLogP of -8.19, 26 rotatable bonds, 20 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S,6S,9S,15R,18R,21R,25R)-3,15-bis(2-amino-2-oxoethyl)-25-[(2R,3R,4S)-2,3-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentadecyl]-18-[(R)-hydroxy-(4-hydroxyphenyl)methyl]-6,21-bis(hydroxymethyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacos-9-yl]acetamide is sourced from PubChem (CID 71460075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).